CRIS Current Research Information System

MARTIGNANI, CRISTIAN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.627
AS - Asia 10.415
EU - Europa 9.093
AF - Africa 603
SA - Sud America 527
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 5
Totale 31.291
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.537
VN - Vietnam 3.168
SG - Singapore 2.759
CN - Cina 2.413
GB - Regno Unito 2.203
IT - Italia 2.075
DE - Germania 1.171
HK - Hong Kong 752
UA - Ucraina 715
SE - Svezia 673
FR - Francia 612
RU - Federazione Russa 504
IN - India 479
BR - Brasile 371
IE - Irlanda 276
NL - Olanda 207
JP - Giappone 200
CI - Costa d'Avorio 191
EE - Estonia 178
KR - Corea 173
FI - Finlandia 161
ZA - Sudafrica 161
TG - Togo 85
AR - Argentina 74
SC - Seychelles 73
PH - Filippine 65
CH - Svizzera 63
BG - Bulgaria 57
JO - Giordania 54
BD - Bangladesh 51
CA - Canada 44
IQ - Iraq 43
TH - Thailandia 43
NG - Nigeria 40
BE - Belgio 35
IR - Iran 31
MX - Messico 31
AT - Austria 29
ID - Indonesia 29
PL - Polonia 27
TW - Taiwan 24
PK - Pakistan 23
TR - Turchia 23
EC - Ecuador 22
SA - Arabia Saudita 22
GR - Grecia 21
AU - Australia 19
ES - Italia 17
CL - Cile 15
RO - Romania 15
EG - Egitto 14
UZ - Uzbekistan 13
CO - Colombia 12
PY - Paraguay 11
MA - Marocco 10
CZ - Repubblica Ceca 7
LT - Lituania 7
MY - Malesia 7
PE - Perù 7
UY - Uruguay 7
VE - Venezuela 7
DZ - Algeria 6
LB - Libano 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
KZ - Kazakistan 5
OM - Oman 5
RS - Serbia 5
ET - Etiopia 4
HR - Croazia 4
HU - Ungheria 4
NO - Norvegia 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
AL - Albania 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EU - Europa 3
IL - Israele 3
JM - Giamaica 3
LU - Lussemburgo 3
MN - Mongolia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
DK - Danimarca 2
HN - Honduras 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
PT - Portogallo 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CM - Camerun 1
Totale 31.274
Salva come PNG Salva come JPEG
Città #
Southend 1.919
Singapore 1.902
Ashburn 1.095
Fairfield 954
San Jose 779
Hong Kong 709
Chandler 632
Ho Chi Minh City 585
Jacksonville 524
Santa Clara 499
Wilmington 494
Hanoi 466
Seattle 450
Dong Ket 449
Woodbridge 444
Princeton 442
Houston 423
Hefei 344
Cambridge 310
Beijing 308
Ann Arbor 285
Dublin 276
Boardman 263
Lauterbourg 210
Westminster 201
Padova 200
Nanjing 197
Abidjan 191
Los Angeles 191
Tokyo 182
Milan 172
Bologna 168
Helsinki 139
Seoul 130
Berlin 122
Rome 117
Saint Petersburg 112
New York 106
Buffalo 104
Shenyang 103
Medford 100
Jinan 93
Bremen 92
Changsha 90
Lomé 85
Mülheim 82
Da Nang 75
Turin 74
Dallas 70
San Diego 68
Mahé 67
Nanchang 64
Haiphong 63
Frankfurt am Main 61
Guangzhou 57
Sofia 57
Munich 54
Hebei 53
Amman 51
Redondo Beach 48
The Dalles 44
Bern 43
Des Moines 43
Olalla 43
Jiaxing 42
Tianjin 42
Council Bluffs 40
São Paulo 40
Abeokuta 38
Zhengzhou 37
Shanghai 35
Verona 35
Bari 34
Naples 34
Bengaluru 33
Brussels 33
Hải Dương 33
Chicago 32
Hangzhou 32
Ningbo 31
Biên Hòa 28
Yubileyny 27
Can Tho 26
Falkenstein 25
London 23
Norwalk 23
Florence 22
Haikou 22
Mountain View 22
Ninh Bình 22
Dearborn 21
Phoenix 21
Taizhou 21
Baghdad 19
Chengdu 19
Düsseldorf 19
Johannesburg 19
Lanzhou 19
Nuremberg 19
Warsaw 19
Totale 19.781
Salva come PNG Salva come JPEG
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.082
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 298
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 286
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 246
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 245
Bridging the future of cardiac stimulation: physiologic or leadless pacing? 232
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 228
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 226
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 221
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 216
Aritimie cardiache, morte cardiaca improvvisa, sincope 216
AF burden is important - Fact or fiction? 214
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 206
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 204
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 203
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 199
Electrocardiographic remodeling during cardiac resynchronization therapy 198
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 197
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 196
Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study 195
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 195
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 193
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 192
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 189
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 189
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 189
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 185
Atrial fibrillation ablation: beyond electro-mechanical matters 184
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 181
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 179
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 178
Implantation of cardioverter-defibrillator: Effects on shoulder function. 176
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 176
Is Less Always More? A Prospective Two-Centre Study Addressing Clinical Outcomes in Leadless versus Transvenous Single-Chamber Pacemaker Recipients 173
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? 173
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 173
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 173
Preoperative checklist to reduce the risk of cardiac implantable electronic device infections 173
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 172
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 172
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 171
Rate control in AFFIRM: considerations about the clinical implications. 170
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 170
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 170
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 170
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 169
Pacing with capture verification in candidates for resynchronisation therapy: a feasibility study. 168
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 165
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 165
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 165
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 165
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 165
Is ventricular sensing always right, when it is left? 164
Predictors of long-term survival free from relapses after extraction of infected CIED. 163
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 162
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 162
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 162
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 158
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 158
Poor Glycaemic Control and Arrhythmias. 158
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 157
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 156
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 155
Atrial fibrillation and heart failure: does one epidemic feed he other? 155
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 154
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 153
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 152
Cardiac resynchronisation therapy: effect on diastolic function –Evaluation by radionuclide angiography 151
The QRS interval in patients treated with resynchronization therapy: which value 151
Long-Term Atrioventricular Block Following Valve Surgery: Electrocardiographic and Surgical Predictors 150
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 150
Phrenic stimulation: a challenge for cardiac resynchronization therapy 149
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 149
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. 149
Non-valvular atrial fibrillation: Potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants 148
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia 148
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry 147
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 147
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. 147
Effetti emodinamici del pacing biventricolare a distanza di un anno dall'impianto 146
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 146
Atrial fibrillation: Adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. 145
Biventricular pacing in heart failure: what relationship between electrocardiographic and structural remodeling? 144
Cardiac resynchronization by pacing: an electrical treatment of heart failure 143
Single versus dual-chamber ICDs : evaluation of rhythm discrimination QRS morphology. 142
Atrial fibrillation in patients with cardiac resynchronization therapy: Clinical management and outcome 142
Atrial fibrillation in patients with a dual defibrillator: characteristics of spontaneous and induced episodes and effect of ventricular tachyarrhythmia induction. 142
The Challenges of Diagnosis and Treatment of Arrhythmogenic Cardiomyopathy: Are We there yet? 141
Follow-up a lungo termine di pazienti con sincope valutati con tilt test 141
A plateau waveform shape allows a much higher patient shock energy tolerance 141
Risultati a lungo termine della cardioversione elettrica di fibrillazione o flutter atriale. 140
Is cardiac resynchronization therapy cost-effective? 140
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. 140
Role of drugs and devices in patients at risk of sudden cardiac death. 140
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 139
La cardioversione elettrica nella pratica clinica:quali predittori di efficacia della procedura e di recidiva di fibrillazione/flutter atriale a lungo termine? 139
Prevention of infections in cardiovascular implantable electronic devices beyond the antibiotic agent 139
Ventricular dyssynchrony at rest and during exercise assessed by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 138
Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations. 138
Peri-operative management of patients taking antithrombotic therapy: need for an integrated proactive approach. 138
Totale 18.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.592 0 0 0 0 0 0 0 0 0 155 134 1.303
2021/20223.403 334 173 219 292 326 228 48 271 104 154 607 647
2022/20233.769 365 452 189 501 217 221 115 196 666 218 319 310
2023/20241.162 93 178 88 79 119 228 83 75 62 58 40 59
2024/20254.275 189 797 318 312 801 196 189 111 56 268 177 861
2025/20269.030 887 854 949 678 1.005 579 1.115 681 1.687 595 0 0
Totale 31.786